ELVN$44.580.75%0.33
Nachbörslich: 44.63+0.05 +0.11%
Enliven Therapeutics Inc (ELVN)
Date: 2026-11-02 16:00O: 44.48H: 45.06L: 43.23C: 44.58Vol: 708.7k
Schlusskurs vom Vortag:
$44.25
Offen:
$44.48
24-Stunden-Volumen:
708,723
Relatives Volumen:
0.38
Marktkapitalisierung:
$3.27B
Einnahmen:
-
Nettoeinkommen (Verlust:
-$98.78M
KGV:
-
EPS:
-$1.66
Netto-Cashflow:
-$65.60M
1W Leistung:
+7.45%
1M Leistung:
-5.09%
6M Leistung:
+6.91%
1Y Leistung:
+90.35%
1-Tages-Spanne:
$43.23$45.06
1-Wochen-Bereich:
$41.52$45.87
52-Wochen-Spanne:
$14.79$62.32
Enliven Therapeutics Inc Aktie (ELVN) Unternehmensprofil
Firmenname
Enliven Therapeutics IncSektor
HealthcareBranche
BiotechnologyTelefon
720-647-8519Adresse
6200 LOOKOUT ROAD, BOULDER, USAELVN vs. VRTX, REGN, MRNA, ARGX, ONC vergleichen
| Aktien | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|
ELVN Enliven Therapeutics Inc | $3.27B | $0 | -$105.93M | -$67.04M | -$1.66 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Enliven Therapeutics Inc Aktie (ELVN) Hochstufungen & Herabstufungen
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Enliven Therapeutics Inc-Aktie (ELVN) Insiderhandel
- Hohl BenjaminOct 19 '26CHIEF FINANCIAL OFFICER
- Transaktion
- Sale
- Kosten
- $38.48
- #Aktien
- 6,018
- Wert ($)
- 231,546
- #Aktien Gesamt
- 38,000
- Collins Helen LouiseOct 19 '26Director
- Transaktion
- Proposed Sale
- Kosten
- $37.32
- #Aktien
- 15,000
- Wert ($)
- 559,800
- #Aktien Gesamt
- 0
- Hohl BenjaminOct 19 '26CHIEF FINANCIAL OFFICER
- Transaktion
- Option Exercise
- Kosten
- $14.85
- #Aktien
- 6,018
- Wert ($)
- 89,367
- #Aktien Gesamt
- 44,018
- Collins Helen LouiseOct 19 '26CHIEF MEDICAL OFFICER
- Transaktion
- Sale
- Kosten
- $38.47
- #Aktien
- 5,000
- Wert ($)
- 192,342
- #Aktien Gesamt
- 25,000
- Collins Helen LouiseOct 19 '26CHIEF MEDICAL OFFICER
- Transaktion
- Option Exercise
- Kosten
- $2.48
- #Aktien
- 5,000
- Wert ($)
- 12,400
- #Aktien Gesamt
- 30,000
- Garland J. ScottOct 01 '26Director
- Transaktion
- Sale
- Kosten
- $46.67
- #Aktien
- 13,000
- Wert ($)
- 606,719
- #Aktien Gesamt
- 0
- Garland J. ScottOct 01 '26Director
- Transaktion
- Option Exercise
- Kosten
- $15.47
- #Aktien
- 13,000
- Wert ($)
- 201,110
- #Aktien Gesamt
- 13,000
- JEFFREY GARLANDOct 01 '26Director
- Transaktion
- Proposed Sale
- Kosten
- $46.67
- #Aktien
- 13,000
- Wert ($)
- 606,719
- #Aktien Gesamt
- 0
- Collins Helen LouiseSep 17 '26CHIEF MEDICAL OFFICER
- Transaktion
- Sale
- Kosten
- $50.35
- #Aktien
- 5,000
- Wert ($)
- 251,754
- #Aktien Gesamt
- 25,000
- Collins Helen LouiseSep 17 '26CHIEF MEDICAL OFFICER
- Transaktion
- Option Exercise
- Kosten
- $2.48
- #Aktien
- 5,000
- Wert ($)
- 12,400
- #Aktien Gesamt
- 30,000
